Skip to content

Leilani Raquepo Ragasa, M.D.

NPI 1073668166ActiveIndividual· Clinic/Center, Primary Care· Los Angeles, CA

Clinic/Center, Primary Care (M.D.) in Los Angeles, California, licensed in CA, with an NPI issued in January 2007. Part D covered 127 prescriptions written in 2024, 73% of them generic. Astrazeneca Pharmaceuticals LP reported $123.36 in payments in 2024, mostly food and beverage.

Overview

NPI1073668166
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedJan 25, 2007
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Clinic/Center, Primary Care Primary261QP2300XA54981CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Family Practice (CA)

Part D prescriptions in 2024

Prescriptions (claims)127 · 191 30-day fills
Patients28
Total drug cost$5,912
Generic share73% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$123.36 · 1 payment from 1 company

Top paying companies in 2024

CompanyAmountPayments
Astrazeneca Pharmaceuticals LP$123.361

What the 2024 payments were for

  • Food and Beverage$123.36 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Clinic/Center, Primary Care providers in Los Angeles

All 123 Clinic/Center, Primary Care providers in Los Angeles · All Clinic/Center, Primary Care providers in California